[HTML][HTML] Review of COVID-19 testing and diagnostic methods
O Filchakova, D Dossym, A Ilyas, T Kuanysheva… - Talanta, 2022 - Elsevier
More than six billion tests for COVID-19 has been already performed in the world. The
testing for SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) virus and …
testing for SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) virus and …
Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives
T Dong, M Wang, J Liu, P Ma, S Pang, W Liu… - Chemical Science, 2023 - pubs.rsc.org
The disastrous spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has induced severe public healthcare issues and weakened the global economy …
has induced severe public healthcare issues and weakened the global economy …
Nucleic acid testing of SARS-CoV-2
HM Yoo, IH Kim, S Kim - International Journal of Molecular Sciences, 2021 - mdpi.com
The coronavirus disease 2019 (COVID-19) has caused a large global outbreak. It is
accordingly important to develop accurate and rapid diagnostic methods. The polymerase …
accordingly important to develop accurate and rapid diagnostic methods. The polymerase …
[HTML][HTML] Novel coronavirus disease (COVID-19) pandemic: A recent mini review
The COVID-19, caused by a novel coronavirus, was declared as a global pandemic by WHO
more than five months ago, and we are still experiencing a state of global emergency. More …
more than five months ago, and we are still experiencing a state of global emergency. More …
Validation of real-time RT-PCR for detection of SARS-CoV-2 in the early stages of the COVID-19 outbreak in the Republic of Korea
YS Chung, NJ Lee, SH Woo, JM Kim, HM Kim, HJ Jo… - Scientific Reports, 2021 - nature.com
A real-time reverse transcription polymerase chain reaction (RT-qPCR) assay that does not
require Emergency Use Authorization (EUA) reagents was tested and validated for the …
require Emergency Use Authorization (EUA) reagents was tested and validated for the …
SARS-CoV, MERS-CoV and SARS-CoV-2: a diagnostic challenge
M Ezhilan, I Suresh, N Nesakumar - Measurement, 2021 - Elsevier
The highly pathogenic MERS-CoV, SARS-CoV and SARS-CoV-2 cause acute respiratory
syndrome and are often fatal. These new viruses pose major problems to global health in …
syndrome and are often fatal. These new viruses pose major problems to global health in …
Smart materials-integrated sensor technologies for COVID-19 diagnosis
After the first case has appeared in China, the COVID-19 pandemic continues to pose an
omnipresent threat to global health, affecting more than 70 million patients and leading to …
omnipresent threat to global health, affecting more than 70 million patients and leading to …
Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures
Existing coronavirus named as a severe acute respiratory syndrome coronavirus-2 (SARS-
CoV-2) has speeded its spread across the globe immediately after emergence in China …
CoV-2) has speeded its spread across the globe immediately after emergence in China …
Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay
GA Perchetti, G Pepper, L Shrestha, K LaTurner… - Journal of Clinical …, 2021 - Elsevier
Mass molecular diagnostic testing for the SARS-CoV-2 pandemic has drawn on laboratory
developed tests, commercial assays, and fully-automated platforms to accommodate …
developed tests, commercial assays, and fully-automated platforms to accommodate …
Next-generation computational tools and resources for coronavirus research: From detection to vaccine discovery
The COVID-19 pandemic has affected 215 countries and territories around the world with
60,187,347 coronavirus cases and 17,125,719 currently infected patients confirmed as of …
60,187,347 coronavirus cases and 17,125,719 currently infected patients confirmed as of …